Patients on exchange plans are more likely to see higher out-of-pocket costs for their specialty drugs in 2015 compared with 2014, according to a new analysis from Avalere Health.
Patients on exchange plans are more likely to see higher out-of-pocket costs for their specialty drugs in 2015 compared with 2014, according to a new analysis from Avalere Health.
Plans charging coinsurance greater than 30% for specialty medications for life-threatening illnesses such as cancer, rheumatoid arthritis, or multiple sclerosis, has increased to 41% of silver plans in 2015 from just 27% in 2014. Overall, approximately two-thirds of individuals on the exchanges picked silver plans in 2014 and 28% of exchange enrollees are between the ages of 18 and 34 years.
“Health plans continue to focus on managing drug costs to keep premiums low,” Dan Mendelson, chief executive officer at Avalere Health, said in a statement. “Competitive premiums are key to a sustainable exchange marketplace, which has led plans to pursue more significant cost-sharing. In some cases this could make it difficult for patients to afford and stay on medications.”
More than half (52%) of bronze plans are charging a coinsurance above 30% for specialty tier drugs in 2015 (up from 38% in 2014), while 26% of platinum plans are doing so (up from 17% in 2014). Gold plans are the least likely to be picked.
A total of 80% of silver plans, 91% of bronze plans, 80% of gold, and 66% of platinum plans charge any coinsurance for cost sharing on the specialty tier, Avalere reported. Overall, 63% of plans use coinsurance for specialty drugs.
According to Caroline Pearson, vice president at Avalere, coinsurance can make medication costs unpredictable for consumers, and from year to year the changes in cost-sharing requirements can surprise patients who are medication depedent.
“As a result, consumers who rely on specialty drugs should make sure they are evaluating their plan options in 2015,” she said. “In particular, some patients may be better off paying more in monthly premiums in exchange for lower out-of-pocket costs.”
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
The Federal Trade Commission (FTC) issued letters to 10 companies to warn them that certain drug patents were improperly listed; the US Department of Agriculture (USDA) will begin testing ground beef for bird flu particles; rural Americans are more likely to die early from 1 of the 5 leading causes of death than those who live in urban areas.
Read More